| Company name |
Life Science Institute, Inc. |
| Head office |
THE KAITEKI Building, 13‐4 Uchikanda 1‐chome, Chiyoda‐ku, Tokyo 101‐0047 |
| Representative |
President & CEO Seiichi Kiso |
| Date of incorporation |
April 1, 2014 |
| Paid-in capital |
9,250 million yen |
| Line of business (consolidated) |
Next-generation Healthcare, Healthcare and Medical ICT, and Pharmaceutical Development Solutions |
| Sales revenue (Consolidated) |
23.2 billion（FY2020） |
| Employees (Consolidated) |
562(As of March 31, 2021) |
| Shareholder |
Mitsubishi Chemical Holdings Corporation 100% |
